EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹16 Cr | ₹18 Cr | ₹14 Cr | ₹14 Cr | ₹9.71 Cr |
What is the latest Cash Flow from Operating Activities ratio of EVEREST ORGANICS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹16 Cr |
Mar2023 | ₹18 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹14 Cr |
Mar2020 | ₹9.71 Cr |
How is Cash Flow from Operating Activities of EVEREST ORGANICS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹16 Cr | -10.84 | |
Mar2023 | ₹18 Cr | 34.06 | |
Mar2022 | ₹14 Cr | 1.51 | |
Mar2021 | ₹14 Cr | 39.33 | |
Mar2020 | ₹9.71 Cr | - |
Compare Cash Flow from Operating Activities of peers of EVEREST ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EVEREST ORGANICS | ₹382.8 Cr | -4.3% | 18.1% | 193.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,411.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
EVEREST ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EVEREST ORGANICS | -4.3% |
18.1% |
193.2% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses